Previous 10 | Next 10 |
InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67 Conference call to be held on May 5 at 8:30 a.m. Eastern Time PR Newswire YOKNEAM, Israel, April 12, 2021 /PRNewswire/ -- InMode Ltd. (Nas...
InMode to Present at the Needham 20th Annual Virtual Healthcare Conference PR Newswire YOKNEAM, Israel , March 30, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced Mr. Moshe Mizr...
Founder-owners have demonstrated a strong track record of growth and profitability. The company's pristine balance sheet affords new pathways for growth and share repurchases. The key risk is competition. For further details see: InMode: Fast Growing Small Cap With Consi...
InMode (INMD) has climbed 51% in the past 3 months; the company is a leading global provider of minimally and non-invasive cosmetic procedures, reports Tom Bishop, small cap expert and editor of BI Research. For further details see: Cosmetic Procedures Paint a Pretty Picture at InMode ...
InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera PR Newswire YOKNEAM, Israel , March 16, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the U...
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q4 2020 Earnings Call Feb 10, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: InMode Ltd. (INMD) Q4 2020 Earnings Call Transcript
InMode Ltd. (INMD) Q4 2020 Earnings Conference Call February 10, 2021, 8:30 am ET Company Participants Miri Segal - MS, IR Moshe Mizrahy - CEO & Chairman Michael Kreindel - Co-Founder & CTO Yair Malca - CFO Spero Theodorou - CMO Shakil Lakhani - President, North America Rafi Lickerman...
InMode ([[INMD]] -0.6%) reports record Q4 revenues of $75.2M million, an increase of 60% vs. last year.Revenue breakup: 65% of quarterly revenues derived from our proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments, 28% from recently ...
InMode (INMD): Q4 Non-GAAP EPS of $0.94 beats by $0.19; GAAP EPS of $0.85 beats by $0.18.Revenue of $75.2M (+60.0% Y/Y) beats by $4.43M.Press Release For further details see: InMode EPS beats by $0.19, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...